US Bancorp’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-437
| Closed | -$721 | – | 4238 |
|
|
2024
Q4 | $721 | Sell |
437
-151
| -26% | -$249 | ﹤0.01% | 3991 |
|
|
2024
Q3 | $2.06K | Sell |
588
-987
| -63% | -$3.46K | ﹤0.01% | 3762 |
|
|
2024
Q2 | $5.17K | Buy |
+1,575
| New | +$5.17K | ﹤0.01% | 3490 |
|
|
2024
Q1 | – | Sell |
-7,991
| Closed | -$29.9K | – | 3986 |
|
|
2023
Q4 | $29.9K | Buy |
7,991
+5,586
| +232% | +$20.9K | ﹤0.01% | 2891 |
|
|
2023
Q3 | $5.1K | Sell |
2,405
-1,922
| -44% | -$4.08K | ﹤0.01% | 3415 |
|
|
2023
Q2 | $20.6K | Buy |
4,327
+2,086
| +93% | +$9.93K | ﹤0.01% | 2935 |
|
|
2023
Q1 | $12.8K | Buy |
2,241
+935
| +72% | +$5.33K | ﹤0.01% | 3178 |
|
|
2022
Q4 | $13.2K | Sell |
1,306
-12,424
| -90% | -$125K | ﹤0.01% | 3193 |
|
|
2022
Q3 | $307K | Buy |
13,730
+13,362
| +3,631% | +$299K | ﹤0.01% | 1622 |
|
|
2022
Q2 | $9K | Buy |
368
+68
| +23% | +$1.66K | ﹤0.01% | 3372 |
|
|
2022
Q1 | $11K | Sell |
300
-180
| -38% | -$6.6K | ﹤0.01% | 3319 |
|
|
2021
Q4 | $28K | Sell |
480
-213
| -31% | -$12.4K | ﹤0.01% | 2920 |
|
|
2021
Q3 | $41K | Sell |
693
-97
| -12% | -$5.74K | ﹤0.01% | 2724 |
|
|
2021
Q2 | $68K | Buy |
790
+268
| +51% | +$23.1K | ﹤0.01% | 2496 |
|
|
2021
Q1 | $43K | Buy |
522
+407
| +354% | +$33.5K | ﹤0.01% | 2642 |
|
|
2020
Q4 | $11K | Buy |
115
+98
| +576% | +$9.37K | ﹤0.01% | 3121 |
|
|
2020
Q3 | $1K | Hold |
17
| – | – | ﹤0.01% | 3503 |
|
|
2020
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3506 |
|
|
2018
Q4 | – | Sell |
-922
| Closed | -$15K | – | 3615 |
|
|
2018
Q3 | $15K | Buy |
922
+62
| +7% | +$1.01K | ﹤0.01% | 3002 |
|
|
2018
Q2 | $10K | Buy |
+860
| New | +$10K | ﹤0.01% | 3126 |
|